Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: Hereditary inclusion body myopathy, paget disease of bone, and frontotemporal dementia

Margaret J. Kovach, Brook Waggoner, Suzanne M. Leal, David Gelber, Romesh Khardori, Mark A. Levenstien, Christy A. Shanks, Gregory Gregg, Muhammad T. Al-Lozi, Timothy Miller, Wojtek Rakowicz, Glenn Lopate, Juliane Florence, Guila Glosser, Zachary Simmons, John C. Morris, Michael P. Whyte, Alan Pestronk, Virginia E. Kimonis

Research output: Contribution to journalArticle

155 Citations (Scopus)

Abstract

Autosomal dominant myopathy, Paget disease of bone, and dementia constitute a unique disorder (MIM 605382). Here we describe the clinical, biochemical, radiological, and pathological characteristics of 49 affected (23 male, 26 female) individuals from four unrelated United States families. Among these affected individuals 90% have myopathy, 43% have Paget disease of bone, and 37% have premature frontotemporal dementia. EMG shows myopathic changes and muscle biopsy reveals nonspecific myopathic changes or blue-rimmed vacuoles. After candidate loci were excluded, a genome-wide screen in the large Illinois family showed linkage to chromosome 9 (maximum LOD score 3.64 with marker D9S301). Linkage analysis with a high density of chromosome 9 markers generated a maximum two-point LOD score of 9.29 for D9S1791, with a maximum multipoint LOD score of 12.24 between D9S304 and D9S1788. Subsequent evaluation of three additional families demonstrating similar clinical characteristics confirmed this locus, refined the critical region, and further delineated clinical features of this unique disorder. Hence, autosomal dominant inclusion body myopathy (HIBM), Paget disease of bone (PDB), and frontotemporal dementia (FTD) localizes to a 1.08-6.46 cM critical interval on 9p13.3-12 in the region of autosomal recessive IBM2.

Original languageEnglish (US)
Pages (from-to)458-475
Number of pages18
JournalMolecular Genetics and Metabolism
Volume74
Issue number4
DOIs
StatePublished - Jan 1 2001

Fingerprint

Osteitis Deformans
Frontotemporal Dementia
Chromosomes
Chromosomes, Human, Pair 9
Bone
Muscular Diseases
Biopsy
Vacuoles
Genetic Markers
Dementia
Muscle
Genes
Genome
Muscles
Nonaka type Distal myopathy

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Molecular Biology
  • Genetics
  • Endocrinology

Cite this

Kovach, Margaret J. ; Waggoner, Brook ; Leal, Suzanne M. ; Gelber, David ; Khardori, Romesh ; Levenstien, Mark A. ; Shanks, Christy A. ; Gregg, Gregory ; Al-Lozi, Muhammad T. ; Miller, Timothy ; Rakowicz, Wojtek ; Lopate, Glenn ; Florence, Juliane ; Glosser, Guila ; Simmons, Zachary ; Morris, John C. ; Whyte, Michael P. ; Pestronk, Alan ; Kimonis, Virginia E. / Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families : Hereditary inclusion body myopathy, paget disease of bone, and frontotemporal dementia. In: Molecular Genetics and Metabolism. 2001 ; Vol. 74, No. 4. pp. 458-475.
@article{31b8a64f93e04025a7554992d526c394,
title = "Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: Hereditary inclusion body myopathy, paget disease of bone, and frontotemporal dementia",
abstract = "Autosomal dominant myopathy, Paget disease of bone, and dementia constitute a unique disorder (MIM 605382). Here we describe the clinical, biochemical, radiological, and pathological characteristics of 49 affected (23 male, 26 female) individuals from four unrelated United States families. Among these affected individuals 90{\%} have myopathy, 43{\%} have Paget disease of bone, and 37{\%} have premature frontotemporal dementia. EMG shows myopathic changes and muscle biopsy reveals nonspecific myopathic changes or blue-rimmed vacuoles. After candidate loci were excluded, a genome-wide screen in the large Illinois family showed linkage to chromosome 9 (maximum LOD score 3.64 with marker D9S301). Linkage analysis with a high density of chromosome 9 markers generated a maximum two-point LOD score of 9.29 for D9S1791, with a maximum multipoint LOD score of 12.24 between D9S304 and D9S1788. Subsequent evaluation of three additional families demonstrating similar clinical characteristics confirmed this locus, refined the critical region, and further delineated clinical features of this unique disorder. Hence, autosomal dominant inclusion body myopathy (HIBM), Paget disease of bone (PDB), and frontotemporal dementia (FTD) localizes to a 1.08-6.46 cM critical interval on 9p13.3-12 in the region of autosomal recessive IBM2.",
author = "Kovach, {Margaret J.} and Brook Waggoner and Leal, {Suzanne M.} and David Gelber and Romesh Khardori and Levenstien, {Mark A.} and Shanks, {Christy A.} and Gregory Gregg and Al-Lozi, {Muhammad T.} and Timothy Miller and Wojtek Rakowicz and Glenn Lopate and Juliane Florence and Guila Glosser and Zachary Simmons and Morris, {John C.} and Whyte, {Michael P.} and Alan Pestronk and Kimonis, {Virginia E.}",
year = "2001",
month = "1",
day = "1",
doi = "10.1006/mgme.2001.3256",
language = "English (US)",
volume = "74",
pages = "458--475",
journal = "Molecular Genetics and Metabolism",
issn = "1096-7192",
publisher = "Academic Press Inc.",
number = "4",

}

Kovach, MJ, Waggoner, B, Leal, SM, Gelber, D, Khardori, R, Levenstien, MA, Shanks, CA, Gregg, G, Al-Lozi, MT, Miller, T, Rakowicz, W, Lopate, G, Florence, J, Glosser, G, Simmons, Z, Morris, JC, Whyte, MP, Pestronk, A & Kimonis, VE 2001, 'Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families: Hereditary inclusion body myopathy, paget disease of bone, and frontotemporal dementia', Molecular Genetics and Metabolism, vol. 74, no. 4, pp. 458-475. https://doi.org/10.1006/mgme.2001.3256

Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families : Hereditary inclusion body myopathy, paget disease of bone, and frontotemporal dementia. / Kovach, Margaret J.; Waggoner, Brook; Leal, Suzanne M.; Gelber, David; Khardori, Romesh; Levenstien, Mark A.; Shanks, Christy A.; Gregg, Gregory; Al-Lozi, Muhammad T.; Miller, Timothy; Rakowicz, Wojtek; Lopate, Glenn; Florence, Juliane; Glosser, Guila; Simmons, Zachary; Morris, John C.; Whyte, Michael P.; Pestronk, Alan; Kimonis, Virginia E.

In: Molecular Genetics and Metabolism, Vol. 74, No. 4, 01.01.2001, p. 458-475.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Clinical delineation and localization to chromosome 9p13.3-p12 of a unique dominant disorder in four families

T2 - Hereditary inclusion body myopathy, paget disease of bone, and frontotemporal dementia

AU - Kovach, Margaret J.

AU - Waggoner, Brook

AU - Leal, Suzanne M.

AU - Gelber, David

AU - Khardori, Romesh

AU - Levenstien, Mark A.

AU - Shanks, Christy A.

AU - Gregg, Gregory

AU - Al-Lozi, Muhammad T.

AU - Miller, Timothy

AU - Rakowicz, Wojtek

AU - Lopate, Glenn

AU - Florence, Juliane

AU - Glosser, Guila

AU - Simmons, Zachary

AU - Morris, John C.

AU - Whyte, Michael P.

AU - Pestronk, Alan

AU - Kimonis, Virginia E.

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Autosomal dominant myopathy, Paget disease of bone, and dementia constitute a unique disorder (MIM 605382). Here we describe the clinical, biochemical, radiological, and pathological characteristics of 49 affected (23 male, 26 female) individuals from four unrelated United States families. Among these affected individuals 90% have myopathy, 43% have Paget disease of bone, and 37% have premature frontotemporal dementia. EMG shows myopathic changes and muscle biopsy reveals nonspecific myopathic changes or blue-rimmed vacuoles. After candidate loci were excluded, a genome-wide screen in the large Illinois family showed linkage to chromosome 9 (maximum LOD score 3.64 with marker D9S301). Linkage analysis with a high density of chromosome 9 markers generated a maximum two-point LOD score of 9.29 for D9S1791, with a maximum multipoint LOD score of 12.24 between D9S304 and D9S1788. Subsequent evaluation of three additional families demonstrating similar clinical characteristics confirmed this locus, refined the critical region, and further delineated clinical features of this unique disorder. Hence, autosomal dominant inclusion body myopathy (HIBM), Paget disease of bone (PDB), and frontotemporal dementia (FTD) localizes to a 1.08-6.46 cM critical interval on 9p13.3-12 in the region of autosomal recessive IBM2.

AB - Autosomal dominant myopathy, Paget disease of bone, and dementia constitute a unique disorder (MIM 605382). Here we describe the clinical, biochemical, radiological, and pathological characteristics of 49 affected (23 male, 26 female) individuals from four unrelated United States families. Among these affected individuals 90% have myopathy, 43% have Paget disease of bone, and 37% have premature frontotemporal dementia. EMG shows myopathic changes and muscle biopsy reveals nonspecific myopathic changes or blue-rimmed vacuoles. After candidate loci were excluded, a genome-wide screen in the large Illinois family showed linkage to chromosome 9 (maximum LOD score 3.64 with marker D9S301). Linkage analysis with a high density of chromosome 9 markers generated a maximum two-point LOD score of 9.29 for D9S1791, with a maximum multipoint LOD score of 12.24 between D9S304 and D9S1788. Subsequent evaluation of three additional families demonstrating similar clinical characteristics confirmed this locus, refined the critical region, and further delineated clinical features of this unique disorder. Hence, autosomal dominant inclusion body myopathy (HIBM), Paget disease of bone (PDB), and frontotemporal dementia (FTD) localizes to a 1.08-6.46 cM critical interval on 9p13.3-12 in the region of autosomal recessive IBM2.

UR - http://www.scopus.com/inward/record.url?scp=18244381306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18244381306&partnerID=8YFLogxK

U2 - 10.1006/mgme.2001.3256

DO - 10.1006/mgme.2001.3256

M3 - Article

C2 - 11749051

AN - SCOPUS:18244381306

VL - 74

SP - 458

EP - 475

JO - Molecular Genetics and Metabolism

JF - Molecular Genetics and Metabolism

SN - 1096-7192

IS - 4

ER -